A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.
NCT06691685
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
ESO-T01 Injection
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators
[object Object]